About PathAI
PathAI is a company based in Boston (United States) founded in 2016 by Andrew H Beck. PathAI has raised $254.94 million across 5 funding rounds from investors including Kaiser Permanente, LabCorp and General Atlantic. The company has 573 employees as of December 31, 2023. PathAI has completed 1 acquisition, including Poplar Healthcare. PathAI operates in a competitive market with competitors including Viz.ai, Deepcell, Deciphex, Aignostics and Pictor Labs, among others.
- Headquarter Boston, United States
- Employees 573 as on 31 Dec, 2023
- Founders Andrew H Beck
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Pathai, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$254.94 M (USD)
in 5 rounds
-
Latest Funding Round
$165 M (USD), Series C
May 18, 2021
-
Investors
Kaiser Permanente
& 15 more
-
Employee Count
573
as on Dec 31, 2023
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of PathAI
Unlock access to complete
Leadership Team
16 people
Software Development Team
12 people
Product Management Team
10 people
Machine Team
9 people
Senior Team
7 people
Human Resources and Administration
5 people
Data Analysis and Operations Team
5 people
Clinical Team
4 people
Unlock access to complete
Funding Insights of PathAI
PathAI has successfully raised a total of $254.94M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $165 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in PathAI
PathAI has secured backing from 16 investors, including institutional and venture fund investors. Prominent investors backing the company include Kaiser Permanente, LabCorp and General Atlantic.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity fund focused on global markets
|
Locked | Locked | Locked | |
|
Venture and private equity investments are managed with global diversification.
|
Locked | Locked | Locked | |
|
Biospring is engaged in partnering with pharma services businesses.
|
Locked | Locked | Locked |
Investor details for PathAI
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PathAI
PathAI has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Poplar Healthcare.
Investment portfolio details for PathAI
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Pathology laboratory services are operated across a chain of facilities.
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for PathAI
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - PathAI
Detailed financials for PathAI
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Pathai Comparisons
Peer comparison for PathAI
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of PathAI
PathAI operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viz.ai, Deepcell, Deciphex, Aignostics and Pictor Labs, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
AI-based tools for pathological image analysis are provided to labs.
|
Detailed competitors of PathAI
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Pathai
Complete news archive for PathAI
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PathAI
PathAI was founded in 2016 and raised its 1st funding round 1 year after it was founded.
PathAI is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Andrew H Beck is the current CEO of PathAI. They have also founded this company.
PathAI is a funded company, having raised a total of $254.94M across 5 funding rounds to date.
As of Dec 31, 2023, the latest employee count at PathAI is 573.
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases. The company is applying deep learning techniques to massive aggregated sets of pathology data to build models that can automatically detect and diagnose medical conditions.
PathAI's top competitors include Aignostics, Deciphex and Pictor Labs.
PathAI has made 1 acquisition, including Poplar Healthcare.
PathAI has 16 investors. Key investors include Kaiser Permanente, LabCorp, General Atlantic, Bristol-Myers Squibb, and Tiger Global.